X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1256) 1256
Patent (34) 34
Publication (15) 15
Book Chapter (2) 2
Web Resource (2) 2
Book / eBook (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (718) 718
life sciences & biomedicine (712) 712
humans (662) 662
cardiovascular system & cardiology (567) 567
cardiac & cardiovascular systems (520) 520
female (467) 467
male (459) 459
aged (398) 398
middle aged (377) 377
stents (308) 308
treatment outcome (279) 279
cardiovascular (200) 200
risk factors (194) 194
stent (191) 191
coronary angiography (168) 168
cardiology and cardiovascular medicine (162) 162
mortality (155) 155
heart attacks (152) 152
drug-eluting stents (146) 146
care and treatment (135) 135
abridged index medicus (127) 127
internal medicine (124) 124
time factors (124) 124
cardiac patients (119) 119
percutaneous coronary intervention (117) 117
cardiology (116) 116
myocardial infarction (110) 110
coronary heart disease (109) 109
follow-up studies (109) 109
restenosis (107) 107
analysis (104) 104
angioplasty, balloon, coronary (104) 104
peripheral vascular disease (103) 103
angioplasty (102) 102
coronary artery disease (102) 102
transluminal angioplasty (101) 101
coronary vessels (98) 98
prognosis (97) 97
myocardial infarction - therapy (96) 96
ticlopidine - analogs & derivatives (94) 94
thrombosis (93) 93
platelet aggregation inhibitors - therapeutic use (86) 86
cardiovascular disease (79) 79
coronary artery disease - therapy (79) 79
heart attack (77) 77
drug therapy (76) 76
prospective studies (76) 76
general & internal medicine (74) 74
medicine, general & internal (74) 74
randomized controlled trials as topic (74) 74
drug-eluting stent (72) 72
risk assessment (69) 69
sirolimus - administration & dosage (69) 69
percutaneous coronary intervention - adverse effects (67) 67
clinical trials (64) 64
kaplan-meier estimate (64) 64
myocardial infarction - mortality (64) 64
proportional hazards models (64) 64
prosthesis design (64) 64
clopidogrel (62) 62
coronary artery disease - mortality (62) 62
coronary restenosis - prevention & control (59) 59
aged, 80 and over (58) 58
diabetes (58) 58
retrospective studies (58) 58
multivariate analysis (57) 57
platelet aggregation inhibitors - administration & dosage (57) 57
studies (57) 57
coronary disease - therapy (56) 56
recurrence (56) 56
acute coronary syndromes (54) 54
predictive value of tests (54) 54
hematology (51) 51
patients (51) 51
survival analysis (51) 51
ticlopidine - administration & dosage (49) 49
ticlopidine - therapeutic use (49) 49
myocardial infarction - etiology (48) 48
electrocardiography (46) 46
percutaneous coronary intervention - mortality (46) 46
health aspects (45) 45
genotype (44) 44
germany (44) 44
medical imaging (44) 44
research (44) 44
patient outcomes (43) 43
stent thrombosis (42) 42
coronary artery disease - diagnostic imaging (41) 41
meta-analysis (41) 41
double-blind method (40) 40
medicine & public health (40) 40
biomarkers - blood (39) 39
confidence intervals (39) 39
medical research (38) 38
paclitaxel - administration & dosage (38) 38
usage (38) 38
angioplasty, balloon, coronary - adverse effects (37) 37
incidence (37) 37
drug therapy, combination (36) 36
angioplasty, balloon, coronary - methods (35) 35
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1263) 1263
Spanish (35) 35
German (23) 23
French (22) 22
Polish (11) 11
Portuguese (3) 3
Italian (2) 2
Russian (2) 2
Romanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 02/2016, Volume 387, Issue 10018, pp. 537 - 544
Summary Background Bioresorbable coronary stents might improve outcomes of patients treated with percutaneous coronary interventions. The everolimus-eluting... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Drug-Eluting Stents | Humans | Middle Aged | Graft Occlusion, Vascular - prevention & control | Myocardial Revascularization - methods | Male | Treatment Outcome | Everolimus - administration & dosage | Myocardial Ischemia - drug therapy | Absorbable Implants | Randomized Controlled Trials as Topic | Tissue Scaffolds | Percutaneous Coronary Intervention - instrumentation | Graft Occlusion, Vascular - etiology | Percutaneous Coronary Intervention - methods | Reoperation - statistics & numerical data | Female | Aged | Myocardial Infarction - prevention & control | Myocardial Infarction - etiology | Myocardial Revascularization - instrumentation | Immunosuppressive Agents - administration & dosage | Angiogenesis inhibitors | Analysis | Cardiac patients | Stent (Surgery) | Cardiovascular agents | Transluminal angioplasty | Heart | Medical research | Medicine, Experimental | Heart diseases | Thrombosis | Blood clot | Studies | Heart attacks | Cardiovascular disease | Acute coronary syndromes | Stents | Clinical outcomes | Meta-analysis | Myocardial infarction | Surgical implants | Websites | Funding | Bias | Clinical trials | Risk | Evidence-based medicine | Biomedical materials | Randomization | Ischemia | Implants | Biocompatibility | Safety | Lesions | Thromboembolism | Statistical analysis | Mortality | Blood vessels | Implantation | Coronary artery disease | Death | Diabetes | Cardiovascular diseases | Scaffolds
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 05/2013, Volume 61, Issue 20, pp. 2060 - 2066
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2009, Volume 53, Issue 10, pp. 849 - 856
Objectives The aim of this prospective trial was to assess whether platelet reactivity to clopidogrel assessed with multiple electrode platelet aggregometry... 
Cardiovascular | Internal Medicine | clopidogrel | whole blood aggregometry | stent thrombosis | platelet aggregation | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Prospective Studies | Platelet Function Tests - methods | Ticlopidine - pharmacology | Ticlopidine - therapeutic use | Humans | Kaplan-Meier Estimate | Male | Thrombosis - epidemiology | Coronary Artery Disease - mortality | Electric Impedance | Ticlopidine - analogs & derivatives | Drug-Eluting Stents - adverse effects | Electrodes | Coronary Artery Disease - therapy | Point-of-Care Systems | Thrombosis - etiology | Ticlopidine - adverse effects | Platelet Aggregation Inhibitors - pharmacology | Female | Platelet Function Tests - instrumentation | Aged | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Transluminal angioplasty | Coenzymes | Vasodilators | Adenosine diphosphate | Coronary heart disease | Thrombosis | Stent (Surgery) | Blood clot | Aggregation | Disease transmission | Blood platelets | Analysis | Adenosine triphosphatase | Drug therapy | Intervention | Anticoagulants | Aspirin | Heart attacks | Medical imaging | Cardiovascular disease | Studies | Confidence intervals | Coronary vessels | Acute coronary syndromes | Stents | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 67, Issue 8, pp. 932 - 935
Journal Article